Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
BeOne Medicines
BeOne Medicines
Seagen Inc.
Merck Sharp & Dohme LLC
ImmunityBio, Inc.
EMD Serono
Janssen Research & Development, LLC
BeOne Medicines
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Merck Sharp & Dohme LLC
Genentech, Inc.
EMD Serono
UroGen Pharma Ltd.
ImmunityBio, Inc.
Tyra Biosciences, Inc
CG Oncology, Inc.
Hoffmann-La Roche
Pangea Laboratory LLC
Inhibrx Biosciences, Inc
Merck Sharp & Dohme LLC
Exelixis
AbbVie
OncoC4, Inc.
Klus Pharma Inc.
Checkpoint Therapeutics, Inc.
Cybrexa Therapeutics
Carisma Therapeutics Inc
UroGen Pharma Ltd.
Salubris Biotherapeutics Inc
RemeGen Co., Ltd.